COREV 2.0 PMCF-Study on Manual and Navigated Revision Knee Patients

NCT ID: NCT05113303

Last Updated: 2025-08-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-16

Study Completion Date

2024-03-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Columbus® Revision endoprosthetic system is bearing the CE-mark. This means that within the scope of this observational study the patient will not be subjected to any additional stressful, study-related medical examinations or treatment measures. The treatment will be carried out exclusively according to medical standards. The study therefore only serves the purpose of observing this standard-compliant treatment and specifically documenting it scientifically.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study's main purpose is the collection of clinical data on the safety and performance of the Columbus® Revision Knee endoprosthesis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Bone; Deformity, Congenital Prosthesis Failure Prosthesis-Related Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

navigation assisted knee revision surgery

Navigated Revision Total Knee Arthroplasty

Intervention Type DEVICE

Patients in the case group receive a Columbus® Revision knee prosthesis, implanted with computer assisted surgery

manual procedure

Manual Revision Total Knee Arthroplasty

Intervention Type DEVICE

Patients in the control group will correspond to a historical cohort of patients in which manual jig-assisted knee revision was done.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Navigated Revision Total Knee Arthroplasty

Patients in the case group receive a Columbus® Revision knee prosthesis, implanted with computer assisted surgery

Intervention Type DEVICE

Manual Revision Total Knee Arthroplasty

Patients in the control group will correspond to a historical cohort of patients in which manual jig-assisted knee revision was done.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient underwent navigated revision surgery using the Columbus® Revision knee prosthesis (case group)
* Patient underwent conventional manual revision surgery using another implant system (control group)
* Written informed consent

Exclusion Criteria

* Pregnancy
* Patient Age at time of revision surgery \< 18 years
* Allergy to any prosthesis component
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

B.Braun Surgical SA

INDUSTRY

Sponsor Role collaborator

Aesculap AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilio Larrazabal Raluy, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario Cruces, Spain

Igor Gonzales, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario Cruces, Spain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario Cruces

Barakaldo, Bizkaia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAG-O-H-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

10003 PRO Current Products
NCT01497730 COMPLETED